History
2001. The late President George H.W. Bush, the forty-first President of the United States, asked Robert A. Ingram, then the CEO of GlaxoWellcome, to convene and chair the CEO Roundtable on Cancer, a national forum bringing together key cancer leaders from government, business, academia and nonprofit sectors, all of whom shared a common vision: eliminating cancer.
2005. The Life Sciences Council (LSC) is formed to bring together representatives of oncology pharmaceutical / biotechnology companies to advise the CEO Roundtable on Cancer about ways to enable research and development to deliver more effective oncology therapies to patients faster.
2006. The CEO Roundtable launches the CEO Cancer Gold Standard,™ a workplace wellness accreditation program that encourages and celebrates organizations committed to reducing the risk and burden of cancer among employees, families, and communities.
2011. Eli Lilly and Co. becomes the 100th employer to receive CEO Cancer Gold Standard accreditation.
2014. The CEO Roundtable launches Project Data Sphere, a collaborative effort to advance cancer research by leveraging big data analytics on aggregated clinical trial datasets.
2015. The CEO Roundtable on Cancer-China is launched to bring the CEO Cancer Gold Standard’s employer-led health and wellness model to China.
2016. The CEO Cancer Gold Standard now covers 5 million lives at its 10-year anniversary.
2017. Project Data Sphere reaches 133 research studies, representing more than 100,000 patient lives.
2018. Project Data Sphere launched the Images and Algorithms Initiative to develop AI models for automated assessment of tumor dynamics.
2022. The CEO Roundtable launches Going for Gold, which extends the CEO Cancer Gold Standard™ employer accreditation to recognize universities that champion health and well-being by advancing prevention, diagnosis, and quality treatment for cancer for their students, faculty, staff, alumni, parents, and communities.
2005. The Life Sciences Council (LSC) is formed to bring together representatives of oncology pharmaceutical / biotechnology companies to advise the CEO Roundtable on Cancer about ways to enable research and development to deliver more effective oncology therapies to patients faster.
2006. The CEO Roundtable launches the CEO Cancer Gold Standard,™ a workplace wellness accreditation program that encourages and celebrates organizations committed to reducing the risk and burden of cancer among employees, families, and communities.
2011. Eli Lilly and Co. becomes the 100th employer to receive CEO Cancer Gold Standard accreditation.
2014. The CEO Roundtable launches Project Data Sphere, a collaborative effort to advance cancer research by leveraging big data analytics on aggregated clinical trial datasets.
2015. The CEO Roundtable on Cancer-China is launched to bring the CEO Cancer Gold Standard’s employer-led health and wellness model to China.
2016. The CEO Cancer Gold Standard now covers 5 million lives at its 10-year anniversary.
2017. Project Data Sphere reaches 133 research studies, representing more than 100,000 patient lives.
2018. Project Data Sphere launched the Images and Algorithms Initiative to develop AI models for automated assessment of tumor dynamics.
2022. The CEO Roundtable launches Going for Gold, which extends the CEO Cancer Gold Standard™ employer accreditation to recognize universities that champion health and well-being by advancing prevention, diagnosis, and quality treatment for cancer for their students, faculty, staff, alumni, parents, and communities.
President George H.W. Bush, Robert A. Ingram, and Dr. Martin J Murphy in 2001
